USA - New York Stock Exchange - NYSE:CRD.A - US2246332066 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to CRD.A. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-18 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-07 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-13 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-13 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-03-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-08-11 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-05-11 | Barrington Research | Maintains | Outperform |
| 2022-11-16 | Barrington Research | Maintains | Outperform |
| 2022-08-12 | Barrington Research | Maintains | Outperform |
11 analysts have analysed CRD.A and the average price target is 15.29 USD. This implies a price increase of 39.85% is expected in the next year compared to the current price of 10.93.
The consensus rating for CRAWFORD & COMPANY -CL A (CRD.A) is 87.2727 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering CRAWFORD & COMPANY -CL A (CRD.A) is 11.